Skip Navigation

The European Journal of Public Health 1998 8(4):305-312; doi:10.1093/eurpub/8.4.305
© 1998 by European Journal of Public Health
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by NALPAS, B.
Right arrow Articles by DRUCKER, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by NALPAS, B.
Right arrow Articles by DRUCKER, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

INTERNATIONAL HEALTH

State of epidemiological knowledge and national management of hepatitis C virus infection in the European Community, 1996

B. NALPAS1,2, J.C. DESENCLOS1, E. DELAROCQUE-ASTAGNEAU1 and J. DRUCKER1

1Service d'Hépatologie, Inserm U 370 Paris, France
2Réseau National de Santé Publique, St Maurice Cedex France

B. Nalpas, MD, PhD, Réseau National de Santé Publique, 14 rue du Val d'Osne, 94415 St Maurice Cedex, France, tel. +33 1 41796720

Background: Since the identification of the hepatitis C virus (HCV) in 1989, hepatitis C infection has been recognized as an infection of public health importance. However, the magnitude of the problem is not well estimated at the European level. In order to assess the burden of HCV infection and to analyse the prevention and management policies of this illness at the European level, we performed a survey of European Union (EU) member state health authorities. Methods: For this purpose, we collected all currently running policies regarding the surveillance, prevention and medical care of HCV infection in EU states through a questionnaire sent to the public health authorities of each member state. Results: Based on the data reported by the different member-states, we estimated that 2.4–5.0 million subjects are HCV seropositive in the EU. If we assume, in accordance with the literature, that approximately 70% of those seropositive for HCV have a viral multiplication, 1.7–3.5 million subjects are potentially infectious and most of them may need to be treated. However, the level of assessment of HCV burden is very variable from one state to another and needs to be improved. For HCV prevention and management, the current national policies and practices are very heterogeneous. The surveillance systems for HCV developed in the EU countries need to be Improved and harmonized before the establishment of a European surveillance network. Conclusions: Based on these findings, there is need to promote, coordinate, support and fund European collaborations for this major public health problem.

Keywords: European Union, hepatitis C virus, prevention and management


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.